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Background: We have recently reported substantial reductions in blood pressure (BP) out to 2 years with renal sympathetic denervation (RDN) in 
patients with resistant hypertension. However, only a small number of those patients had been followed for 2 years; this report greatly expands the 
number of patients who reached this timepoint.
Methods: Symplicity HTN-I was an open-label cohort study which enrolled 153 patients at sites in Australia, Europe and the United States. Patients 
were required to have systolic BP ≥160 mm Hg despite at least 3 antihypertensive drugs, including a diuretic, at target or maximal tolerated doses. 
Patients with an estimated glomerular filtration rate <45 mL/min or type 1 diabetes mellitus were excluded. 
Results: Baseline age was 57±11 years, 39% of patients were female, 31% had type 2 diabetes mellitus, eGFR was 83±20 mL/min, heart rate 
was 73±13 bpm and BP was 176/98±17/15 mmHg, despite use of an average of 5 antihypertensive medications. Change in BP out to 24 months 
post-RDN procedure is shown in the Table. Additional 30 and 36 month data will be presented. One case of renal artery stenosis was reported at 12 
months. 
Conclusions: BP progressively declines over 2 years in this much larger current cohort of Symplicity HTN-I patients reaching this timepoint. These 
findings suggest that functional re-innervation is unlikely to be occurring, at least out to 2 years post-RDN procedure.
Change in Systolic BP (mm Hg) (95% CI) P-value* Change in Diastolic BP (mm Hg) ( 95% CI) P-value*
1 Month (n=141) -19 (-22.1, -15.9) <0.01 -10 (-12.0, -8.0) <0.01
3 Months ( n=145) -22 (-25.4, -18.6) <0.01 -11 (-13.2, -8.8) <0.01
6 Months (n=139) -21 (-25.9, -16.1) <0.01 -9 (-12.1, -5.9) <0.01
9 Months (n=90) -23 (-27.8, -18.2) <0.01 -12 (-14.8, -9.2) <0.01
12 Months (n=132) -27 (-30.7, -23.3) <0.01 -13 (-15.4, -10.6) <0.01
18 Months (n=58) -26 (-31.2, -20.8) <0.01 -13 (-16.2, -9.8) <0.01
24 Months (n=44) -31 (-36.3, -25.7) <0.01 -16 (-20.4, -11.6) <0.01
